Hope for thousands of MS patients as 'life-changing' drug now on NHS in England
Summary
The NHS in England will now provide fampridine, the first drug that helps people with multiple sclerosis (MS) improve their walking. About 5,000 people with MS each year could benefit from this medicine, which helps nerve signals travel better and supports greater independence.Key Facts
- Fampridine helps people with MS walk by improving nerve signal transmission.
- MS damages the protective covering of nerves, causing problems with muscle control and walking.
- Around 40% of people taking fampridine showed better walking speed and strength in clinical trials.
- Up to 5,000 people in England will be eligible yearly, based on how much their walking is affected.
- Patients will test the drug for up to one month, and only those who benefit will keep using it.
- The drug was previously unavailable on the NHS in England but is offered in Wales, Scotland, and Northern Ireland.
- People like Aysen Slack, who previously paid privately, welcome the NHS offer as it makes the drug affordable.
- The NHS national medical director said the drug could improve freedom and independence for many with MS.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
